Drugs Made In America Acquisition II Corp (DMII)
Drugs Made In America Acquisition II Corp. (NASDAQ: DMII) is a common stock listing of a company with no significant operating business at present. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida. Its stated purpose is to pursue a business combination, which may include a merger, share exchange, asset acquisition, share purchase, recapitalization, or reorganization with one or more businesses.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | P/E Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-DMII
|
$6.93
|
-31.9% Downside
|
Overvalued
|
Not available
|
Not available
|
Fair
|
0.0%
|
49.8x
|
647.8 M
|
648.1 M
|
0.1%
|
78.9%
|
0.7
|
-9.8%
|
